Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2019-05-14 Director's Dealing
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2019-05-14 English
PRIMARY DOCUMENT
Director's Dealing
2019-05-14 English
PRIMARY DOCUMENT
Director's Dealing
2019-05-14 English
SC 13G/A
Major Shareholding Notification
2019-05-10 English
10-Q
Interim / Quarterly Report Q1 2019
2019-05-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes multiple items: Item 2.02 reports the results of operations and financial condition with a press release attached, Item 5.02 discusses changes related to the 2019 Incentive Plan for management bonuses, and Item 7.01 discloses a Regulation FD webcast conference call with prepared remarks attached. The document does not contain full financial statements or detailed financial analysis itself but references a press release and prepared remarks. The presence of management compensation plan details and a conference call transcript excerpt suggests this is a regulatory filing reporting multiple corporate events and disclosures. It is not a full annual or quarterly report, nor a standalone earnings release or call transcript. Given the nature of Form 8-K as a current report for material events and the mixed content, the best classification is Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories. The document length and detail support a high confidence in this classification.
2019-05-08 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.